Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Alogliptin benzoate cost?Dabrafenib patent expiration?Quartette side effects?Tenofovir generic patent?
See the DrugPatentWatch profile for tirzepatide
Medvi (tirzepatide) is the brand name for a once‑weekly injectable medication approved for weight management. The cost can vary widely depending on: | Factor | Typical Impact on Price | |--------|-------------------------| | Insurance coverage | Full coverage → $0–$100/month; partial coverage → $200–$600/month | | Out‑of‑pocket plans | Copay or coinsurance can raise out‑of‑pocket costs to $800–$1,500/month | | Manufacturer’s savings | Manufacturer or pharmacy‑benefit‑manager (PBM) programs can reduce cost by 10–40% | | Geographic location | Pharmacy pricing can differ by state and pharmacy network |
Other Questions About Tirzepatide :